Jaguar Health exchanges preferred stock for common shares with Streeterville Capital

Jaguar Health is converting 3.72 shares of Series Q Preferred Stock into 31,958 shares of common stock held by Streeterville Capital under a May 26, 2026 agreement. The transaction represents a dilutive equity restructuring that simplifies the capital structure.